CrossrefInfokarte
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders
Hepatitis Monthly · 2020-02-09 · 20 (2)
DOI: 10.5812/hepatmon.95101 ↗Abstract
Kein Abstract verfügbar.
EUVIMED